Emyria Share Price and Company Fundamentals
Last traded: Today at 3:39 AM
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
|Primary activities||Operates a network of specialist medical clinics and uses purpose built software and technology to gather clinical data from consenting patients. The anonymised data is commercialised as clinical evidence.|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||D2, 661 Newcastle Street Leederville WA 6007 Australia|
|Phone / Fax||61 8 6559 2800 /|
|Share registry||AUTOMIC REGISTRY SERVICES|
Emyria paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EMD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
EMD's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Emyria.
|Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.||Exec. Chairman||51||200k|
|Dr. Michael Winlo||MD & Director||486.12k|
|Dr. Alistair Vickery||Exec. Medical Director & Director||461.89k|
|Dr. Karen L. Smith L.L.M, L.L.M., M.B.A., M.D., PH.D.||Exec. Director & Chairman of Strategic Advisory Board||53||209.69k|
|Mr. Joseph Daniel Ohayon ACA, MBA Intl Bus.||Chief Financial Officer|
|Ms. Tracie Ernenwein||Head of Research & Drug Devel.|
|Mary-Ann Rennie||Head of Corp. Operations|
|Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA||Company Sec.|
Profitability and management effectiveness
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Emyria is and its enterprise value is .
The EMD's stocks Beta value is 1.15 making it 15% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Emyria (EMD)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Emyria (ASX:EMD) Frequently Asked Questions
1. What is Emyria's Stock Symbol?
Emyria trades on ASX under the ticker symbol "EMD".
2. What is Emyria's stock price today?
One share of EMD stock can currently be purchased for approximately $0.225.
3. How can I contact Emyria?
Emyria's mailing address is D2, 661 Newcastle Street Leederville WA 6007 Australia. The company can be reached via phone at 61 8 6559 2800.
4. What is Emyria's official website?
The official website of Emyria is https://emyria.com.
5. Which share registry manages Emyria's stock?
Emyria's stock is managed by AUTOMIC REGISTRY SERVICES.